Stage IV Cutaneous Squamous Cell Carcinoma of the Head and Neck AJCC v8 Not Yet Recruiting Phase 1 Trials for Pembrolizumab (DB09037)

IndicationStatusPhase
DBCOND0111033 (Stage IV Cutaneous Squamous Cell Carcinoma of the Head and Neck AJCC v8)Not Yet Recruiting1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT04576091Testing the Addition of an Anti-cancer Drug, BAY1895344, With Radiation Therapy to the Usual Pembrolizumab Treatment for Recurrent Head and Neck CancerTreatment